Effectiveness of ENDS, NRT and medication for smoking cessation among cigarette-only users: a longitudinal analysis of PATH Study wave 3 (2015-2016) and 4 (2016-2017), adult data
Conclusion
No differences were found when cessation rates of ENDS, NRT or non-NRT medication were compared. Given uncertainty about the long-term health effect of ENDS and the likelihood of becoming dual users, people who smoke and need assistance quitting should be encouraged to use current Food and Drug Administration-approved cessation methods until more effective methods are developed.
Source: Tobacco Control - Category: Respiratory Medicine Authors: Kaplan, B., Galiatsatos, P., Breland, A., Eissenberg, T., Cohen, J. E. Tags: Open access Original research Source Type: research
More News: Bupropion | Chantix | HIV AIDS | Nicotine | Nicotine Replacement Therapy | Respiratory Medicine | Smokers | Study | Wellbutrin